Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

The influence of antineoplastic treatment on the weight of survivors of childhood cancer.

Teixeira JF., Maia-Lemos PD., Cypriano MD., Pisani LP.

Narrative Review on Type 2 Diabetes, published in J Pediatr (Rio J) (2016) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Pediatr (Rio J) (2016)
Country
Brazil
Reported sample size
—
Source database
PubMed
PMID
27327565
DOI
10.1016/j.jped.2016.04.003

Abstract (original English)

Obesity is a late effect in survivors of childhood cancer and correlates with chronic complications. Survivors of leukemia, brain tumors, and hematopoietic stem cell transplantation are more likely to develop obesity resulting from treatment modalities such as radiotherapy and glucocorticoids. This paper analyzes and integrates the current data available to health professionals in order to clarify strategies that can be used to treat and prevent obesity in childhood cancer survivors. This is a literature review from on scientifically reliable electronic databases. We selected articles published in the last five years and earlier articles of great scientific importance. The mechanisms involved in the pathophysiology of obesity in cancer survivors are not completely understood, but it is believed that damage to the hypothalamus and endocrine disorders such as insulin resistance, leptin resistance, and hormone deficiency may be involved. The body composition of this group includes a predominance of adipose tissue, especially in those undergoing hematopoietic stem cell transplant and total body irradiation. The use of body mass index in these patients may lead to an underestimation of individuals' risk for metabolic complications. Early identification of groups using accurate anthropometric assessments, interventional treatment, and/or preventative measures and counseling is essent

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Central Nervous System NeoplasmsChildHematopoietic Stem Cell TransplantationHumansNeoplasmsPediatric ObesityPrecursor Cell Lymphoblastic Leukemia-LymphomaRadiotherapySurvivors

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research